All In Biotech

Drug Trial Radar · NCT03622060

Intraarterial Nitroglycerin Versus Nicardipine and Radial Artery Occlusion

A Randomized Comparison of Post-procedural/Pre-hemostasis Intraarterial Nitroglycerin Versus Nicardipine to Reduce Radial Artery Occlusion After Transradial Catheterization

Last checked: Nov 20, 2026Latest source record: Jun 4, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

600

Actual

Start

Jun 4, 2018

Primary completion

May 21, 2019

Study completion May 22, 2019

Sponsor

Lead sponsor
Hermina Heart Center KemayoranAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Hermina Hospital Group
First posted
Aug 9, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 16 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A total of 600 patients undergoing coronary procedures via transradial access using 6F sheath were randomized at the end of the procedure to receive either 250-µg nicardipine or 500-µg nitroglycerin administered to the radial artery through the radial sheath before sheath removal. A continuous patent hemostasis was applied in each patient with the use of an oximetry to maintain an oxygen saturation of \>95%, measured in the finger of the accessed arm until compression device was totally removed. The primary outcome is early RAO which was evaluated by color duplex ultrasonography of the accessed arteries at the day after the radial procedure. Secondary outcome was the change of blood pressure at 2-3 minutes after drug administration. Radial artery angiogram was performed after radial sheath insertion and doppler ultrasound of the accesed radial artery was examined at the day after the procedure.

Conditions

  • Radial Artery Injury at Wrist and Hand Level
  • Occlusion of Artery
  • Vasodilation

Interventions

  • NitroglycerinDrug

    200 microgram intraarterial nicardipine and 500 microgram nitroglycerin administered before sheath removal

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. The absence of antegrade radial artery flow by doppler evaluationTime frame: 24 hour
  2. Blood pressure changeTime frame: 2 minutes after drugs administration

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Hermina Heart Center

    Jakarta Pusat, DKI Jakarta, Indonesia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.